Rapid-test and laboratory platform development start-up company BioCode has received a second grant of R7-million from research commercialisation fund the University Technology Fund to finance its development of a rapid inflammation test that can be used as a screening and monitoring tool for inflammation and inflammatory conditions. “We are currently developing a rapid test to detect the inflammatory molecule Serum Amyloid A (SAA) in a drop of blood. "SAA and other inflammatory molecules increase when a person has inflammation,” BioCode co-founder and Stellenbosch University (SU) Physiological Sciences Department head Professor Resia Pretorius says.
from Engineering News | Home https://ift.tt/3iYxNsF
